Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.171

-0.6%

3:54 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Victor Cassella who wrote (522)	9/6/1997 9:37:00 PM
From: Preston Lurie	of 1605

eecp is a treatment for angina patients that are either not 'ready' for bypass, refractory to medication or not willing to undergo surgical treatment except as a last resort. I think that the last criteria I have mentioned is where Vaso's eecp treatments will have the most room to grow and thus give $$ to Vaso, My opinion ONLY. The vasomed site has official reccomendations for patients and clinicians to decide upon candidacy for treatment. I guess I'm saying that from your message's limited info I wonder if his bypass wasn't a medical emergency, if so then of course eecp wasn't an option. P

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next